Galera Therapeutics, Inc. (GRTX)
↓ Download CSVKey ratios (FY2025)
3750.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$2.54M | -$20.16M | -$49.26M | -$51.23M | -$73.37M | -$70.55M | -$50.69M | -$24.25M | — |
| Net Income | $149.05M | -$18.96M | -$59.08M | -$62.22M | -$80.53M | -$74.22M | -$51.93M | -$23.68M | — |
| EPS (Diluted) | $0.64 | $-0.34 | $-1.33 | — | — | — | — | — | — |
| Total Assets | $7.20M | $10.10M | $26.14M | $44.04M | $83.31M | $84.10M | $123.38M | $88.06M | — |
| Total Liabilities | $645.0K | $153.77M | $157.33M | $153.22M | $141.31M | $77.98M | $53.77M | $26.97M | — |
| Shareholders' Equity | $3.97M | -$148.04M | -$131.19M | -$109.18M | -$58.00M | $6.12M | $69.61M | -$104.82M | -$76.11M |
| Cash & Equivalents | $6.38M | $8.29M | $18.26M | $4.27M | $19.86M | $15.87M | $18.36M | $14.81M | — |
| Operating Cash Flow | -$6.05M | -$12.14M | -$44.85M | -$43.43M | -$67.96M | -$59.54M | -$46.66M | -$22.17M | — |
| Capital Expenditures | — | $0 | $59.0K | $25.0K | $283.0K | $457.0K | $633.0K | $347.0K | — |
| Shares Outstanding | 75.46M | 75.46M | 54.39M | 28.51M | 26.46M | 24.98M | 24.81M | 300.6K | — |